Subjective Cognitive Decline Recruiting Phase 2 / 3 Trials for Losartan (DB00678)

IndicationStatusPhase
DBCOND0080585 (Subjective Cognitive Decline)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02913664Risk Reduction for Alzheimer's DiseasePrevention